Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)

Clinical trial NCT00890929 · COMPLETED

Trial details

NCT number: NCT00890929
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Adult Acute Myeloblastic Leukemia

Start date: 2009-04-01
Primary completion: 2011-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.